Why Stem Cell Quality Matters: What Our Independent Study Revealed
TreVita's independent study examined stem cell quality in Mexico. Learn what we discovered and how a Certificate of Analysis helps verify the quality of your stem cells.
When considering stem cell therapy, many patients focus on the treatment itself. They research the procedure, the clinic, and the potential benefits.
But there is another question that deserves just as much attention:
How do you know the stem cells you're receiving are actually high quality?
The answer starts with verification.
TreVita conducted a year-long, independently funded study to evaluate the quality of stem cell products offered by leading providers in Mexico. The goal was to compare what was advertised with what independent testing actually found.
The results highlighted a major concern in the stem cell industry: the quality and quantity of stem cells can vary significantly between providers.
That's why patients need access to transparent information about the cells they receive.
At TreVita, we believe patients should not have to simply take a provider's word for it. They should have access to information that helps verify the quality of their treatment.
What Did Our Independent Study Find?
TreVita partnered with third-party analytical laboratories to test stem cell samples from multiple leading Mexican producers advertised as COFEPRIS-licensed facilities. Samples were purchased through blinded testing and evaluated using standardized flow cytometry methods.
The study examined several important factors, including:
The findings revealed significant differences between advertised and independently measured results.
Key Findings
- More than 90% of laboratories delivered fewer than 25% of the expected viable cell dose.
- Some samples contained less than 1% of the promised live stem cells.
- Cell viability ranged from 18% to 94% across facilities and testing rounds.
- Repeat testing found fluctuations of more than 20% in live cell yield from the same laboratories.
- Some samples also showed variability in MSC marker expression and signs of contamination.
The study showed that not all stem cell products are created equal. The number of cells advertised does not always reflect the number of living, viable cells actually delivered.
These findings reinforce why independent verification and transparency are so important when choosing a stem cell provider.
Why Does Stem Cell Viability Matter?
One of the most important factors in evaluating stem cell quality is viability.
IN INDEPENDENT STUDY
Viability refers to the percentage of cells that are alive at the time of testing. This matters because a product's advertised cell count does not tell the whole story.
For example, a treatment may be advertised as containing a certain number of stem cells. But if a large percentage of those cells are no longer viable, the actual number of living cells available for treatment may be much lower.
That's why patients should look beyond the number of cells listed on a treatment package.
They should also ask:
- How many cells are actually present?
- How many of those cells are alive?
- How was viability measured?
- When were the cells tested?
- Can the provider verify the results?
The more information patients have, the better equipped they are to make informed decisions about their care.
How TreVita Helps Verify Stem Cell Quality
The findings from our independent study reinforce an important principle: patients deserve transparency about the stem cells they receive.
That's why TreVita provides clients with a Certificate of Analysis as part of our commitment to verifying and documenting stem cell quality.
The certificate provides important information about the specific cell product prepared for the patient. It can include details such as:
The Certificate of Analysis also provides viability information over time. This helps demonstrate how the percentage of viable cells can change after testing and storage.
Cell viability refers to the percentage of cells that remain alive and healthy at the time of testing. It is an important part of evaluating the quality of a stem cell product.
By providing this information, TreVita helps patients better understand the product they are receiving rather than relying solely on a provider's claims.
Verification Should Be Part of the Conversation
Our independent study revealed why patients should ask questions before choosing a stem cell provider.
- 1What is the actual cell count?
- 2How many cells are viable?
- 3How is the product tested?
- 4Can the provider provide documentation?
These questions can help patients better understand the quality of the treatment they are considering.
At TreVita, we believe transparency should be a fundamental part of regenerative medicine. Our independent research and Certificate of Analysis program reflect our commitment to giving patients more information about the quality of their stem cell therapy.
Because when you're investing in your health, you deserve to know what you're receiving.
Don't Just Ask How Many Stem Cells You're Getting
Don't just ask how many stem cells you're getting. Ask how many are viable, how they're tested, and whether the provider can verify their quality.